MedTrace Logo

Intravenous Clarithromycin in Septic Syndrome

NCT00297674 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-02-28

No results posted yet for this study

Summary

The aim of this clinical trial is to clarify the clinical efficacy of clarithromycin as immunotherapy for the management of septic syndrome by ventilator-associated pneumonia.

Conditions

  • Sepsis
  • Ventilator Associated Pneumonia

Interventions

DRUG

Intravenous Clarithromycin

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Evangelos J Giamarellos-Bourboulis, MD, PhD · University of Athens, Medical School, Greece

  • Helen Giamarellou, MD, PhD · University of Athens, Medical School, Greece

  • Apostolos Armaganidis, MD, PhD · University of Athens, Medical School, Greece

  • Charis Roussos, MD, PhD · University of Athens, Medical School, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2005-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00297674 on ClinicalTrials.gov